Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemcentinib in Hospitalized COVID-19 Patients (BGBC020)
NCT04890509Phase 2Completed
- Sponsor
- BerGenBio ASA
- Start
- Oct 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bemcentinib in coronavirus disease 2019 (COVID-19), sponsored by BerGenBio ASA. Started Oct 2020; status: completed.
02
Drugs
bemcentinib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04890509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890509.